Non-Profit Trusted Source of Non-Commercial Health Information
The Original Voice of the American Academy of Anti-Aging, Preventative, and Regenerative Medicine
logo logo
Hormones & Pharmacological Agents

RN13

11 years, 11 months ago

456  0
Posted on Dec 30, 2005, 8 p.m. By Bill Freeman

GENERAL DESCRIPTION: RN13 is designed specifically to treat premature aging and geriatric complaints. It acts on cell respiration and metabolism in organs which are particularly affected by aging. RN13 contains 13 different animal source RNAs, as well as vitamins, amino acids, procaine and glutamic acid and biolecithin to improve cerebral activity.

GENERAL DESCRIPTION:

RN13 is designed specifically to treat premature aging and geriatric complaints. It acts on cell respiration and metabolism in organs which are particularly affected by aging. RN13 contains 13 different animal source RNAs, as well as vitamins, amino acids, procaine and glutamic acid and biolecithin to improve cerebral activity. In the body, RNA is responsible for protein biosynthesis, helping to repair and regenerate body tissues and organs. RN13 purports to work on the principle that animal source RNAs from specific organs may stimulate the same organs in humans. RN13 has been shown to make aging individuals more alert and vital and to improve weak concentration, defective memory, anxiety, troubled sleep and lack of appetite.

ROLE FOR ANTI-AGING:

RN13’s anti-aging benefits may include prevention and treatment of premature aging and many types of age-related disorders, lifting of apathy and potential increase in lifespan.

SIDE EFFECTS/CONTRAINDICATIONS:

Side effects are rare but may include mild irritation at the site of an injection and minor allergic reactions such as a skin rash. People suffering disturbances in purine metabolism, such as gout, should avoid RN13 therapy Antibiotics and drugs that suppress the immune system may inhibit RN13’s efficacy.

PHARMACOLOGY:

A multi-combination product, of which each liquid capsule contains macromolecular organ substances out of embryo 0.37ng, placenta 0.lng, amnion 6-pg, funiculus umbilical 60pg, cor 0.2ng, pancreas 0.lng, mucosa intest 0.lng, glandular suprarenal 0.lng, glandular parathyroid 20pg, testes juv. And fet. 0.2ng; as well as mixture of the following drug additives; heparin 5x10-3 IU, L-glutamic acid 10ug, methenolone acetate 4ng, trijod thyroxin HCL 4pg, vitamin E 40ng, vitamin B12 40ng, vitamin B6 40ng, p-amino benzoyldiethylaminoethanol HCL (Procaine) 5ng, biolecithin 10mg, trace elements (Fe, Co, Cu, Mg, Zn, Ca) 1.5ng, sodium dodecyl sulfate 15ug, medium chained triglyceride 410mg.

Distribution: In severe cases RN13 is administered by injection and supplemented by ampules or capsules. In less severe cases 2ml ampules and 0.5ml liquid capsules are available. VitOrgan of Germany manufactures RN13 under the trade name NeyGeront.

Subscribe to our Newsletter

WorldHealth Videos